As of December 31, 2008, Omrix operates as a stand-alone entity reporting through ETHICON, Inc., a Johnson & Johnson company and leading provider of suture, mesh, hemostats and other products for a wide range of surgical procedures. Since 2003, OMRIX has partnered its biosurgical product line for hemostasis with Johnson & Johnson’s Ethicon division, a leader in the market place. This allows each company to do what it does best, utilizing OMRIX’s know-how and manufacturing capabilities, and leveraging Johnson & Johnson’s sales and marketing leadership.